India's pharma and healthcare sector demonstrates resilient investor interest, marked by a 34% year-on-year increase in deal ...

London-headquartered Accord is one of the largest suppliers of chemotherapy products in Europe and is a wholly-owned subsidiary of India's Intas Pharma, which has annual revenues of around $3.4 ...

EU & Emerging markets post signing the LOI by INTAS Pharmaceuticals as its fully owned subsidiary Sakar Healthcare Limited has informed the Exchange about Certificate under Regulation 74 (5) of the ...

But these same areas are now overcrowded, and price wars are common. Companies like Mankind, Sun Pharma, and Intas are looking at combinations of brand innovation, portfolio reshuffling ...

Objective: This study evaluated the quality of 40 generic clarithromycin products from Latin America and Asia. Materials and Methods: The generic products were examined visually, assayed by high ...

Hikma has acquired the FDA-approved Abbreviated New Drug Application for trametinib tablets from Novugen. Hikma also has entered into a commercial agreement with Novugen where Hikma will be ...

They're a group of over-the-counter meds that are arguably the most trusted to soothe aches and fever—and two major stores ...

Shareholders have approved the sale of the UDENYCA franchise to Intas Pharmaceuticals, which is a significant step in Coherus’s strategic shift towards enhancing its oncology portfolio. Additionally, ...

DelveInsight's "Uterine Sarcoma Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth ...

Do you know which goods you should always buy generic instead of opting for the name brands? You might be surprised by some ...

The state began selling its own generic version of Narcan last year for $24 per twin-pack to businesses and local governments, and will now also sell to individual consumers online. A box ...